Youssif, M.; Eid, R.A.; Rabea, H.; Madney, Y.M.; Khaled, A.; Orayj, K.; Attia, D.; Wahsh, E.A.
Evaluation of the Potential Benefits of Trimetazidine in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial. Pharmaceuticals 2025, 18, 1279.
https://doi.org/10.3390/ph18091279
AMA Style
Youssif M, Eid RA, Rabea H, Madney YM, Khaled A, Orayj K, Attia D, Wahsh EA.
Evaluation of the Potential Benefits of Trimetazidine in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial. Pharmaceuticals. 2025; 18(9):1279.
https://doi.org/10.3390/ph18091279
Chicago/Turabian Style
Youssif, Maha, Ragaey Ahmad Eid, Hoda Rabea, Yasmin M. Madney, Arwa Khaled, Khalid Orayj, Dina Attia, and Engy A. Wahsh.
2025. "Evaluation of the Potential Benefits of Trimetazidine in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial" Pharmaceuticals 18, no. 9: 1279.
https://doi.org/10.3390/ph18091279
APA Style
Youssif, M., Eid, R. A., Rabea, H., Madney, Y. M., Khaled, A., Orayj, K., Attia, D., & Wahsh, E. A.
(2025). Evaluation of the Potential Benefits of Trimetazidine in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial. Pharmaceuticals, 18(9), 1279.
https://doi.org/10.3390/ph18091279
